LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K012115
    Device Name
    SERIM BLOOD LEAK TEST STRIP-2
    Manufacturer
    SERIM RESEARCH CORP.
    Date Cleared
    2001-11-30

    (147 days)

    Product Code
    FJD
    Regulation Number
    876.5820
    Type
    Traditional
    Panel
    Gastroenterology/Urology
    Reference & Predicate Devices
    K990206,K896454
    Why did this record match?
    Reference Devices :

    K990206

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Serim Blood Leak Test Strips – 2 provide a rapid and convenient means for testing dialysate for occult blood leaks that may occur during the conventional hemodialysis procedure or continuous renal replacement therapy procedures such as continuous arteriovenous hemodialysis or continuous venovenous hemodialysis.

    Device Description

    The SERIM Blood Leak Test Strips-2 consist of a 0.2 x 0.2 inch reagent pad attached to one end of a white 0.2 x 3.25 inch polystyrene handle. The reagent pad is immersed into a sample, removed immediately and allowed to react for 60 seconds. Then the reagent pad color is compared to two color blocks on the bottle label. One color block marked Negative is yellow with a few green speckles. If a reagent pad has a similar yellow color the dialysate does not contain significant blood. The second color block is green with small yellow speckles and is marked Positive. A reagent pad with green color equal to or darker than this color block indicates the presence of a significant blood leak.

    AI/ML Overview

    Here's an analysis of the acceptance criteria and study detailed in the provided document for the SERIM™ Blood Leak Test Strips-2:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance CriteriaReported Device Performance
    Sensitivity: Positive reading for 1.5 mg/dL hemoglobin (corresponding to approximately 0.1 mL/minute blood loss, well below AAMI recommended limit of 0.35 mL/minute or 5.5 mg/dL hemoglobin)100% Sensitivity: Sixty positive strip readings were obtained with dialysis buffer containing non-hemolyzed blood at 1.5 mg/dL hemoglobin (as determined by the cyanmethemoglobin method).
    Specificity: Negative reading for dialysate without significant blood.100% Specificity: Sixty negative strip readings were obtained with dialysis buffer without blood.
    Clear distinction between Positive and Negative color blocks.Two color blocks on the bottle label (yellow for Negative, green for Positive) provide a clear distinction.

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size: 60 negative samples and 60 positive samples (totaling 120 samples).
    • Data Provenance: The document does not specify the country of origin. The data appears to be from a controlled laboratory study, not directly referenced as prospective or retrospective patient data. It describes "blind studies" using "blood standards" in "dialysis buffer."

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

    • The document does not specify the number of experts or their qualifications for establishing the ground truth. It states that positive ground truth was defined as "1.5 mg/dL hemoglobin, determined by the cyanmethemoglobin method." This implies reliance on a laboratory assay rather than human expert interpretation for the quantitative ground truth. The color block comparison is manual, but the underlying "true" hemoglobin levels were determined by a standard analytical method.

    4. Adjudication Method for the Test Set

    • The document does not mention an adjudication method. The test strips are designed for visual comparison to distinct positive and negative color blocks. The 100% sensitivity and specificity reported suggest no ambiguity in interpretation for the tested samples, implying direct comparison to the color blocks was sufficient, without needing further adjudication.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    • No, a multi-reader multi-case (MRMC) comparative effectiveness study was not done. The study focuses on the standalone performance of the device and its comparison to a predicate device's chemical properties. The document does not discuss human reader performance, either with or without AI assistance.

    6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study

    • Yes, a standalone performance study was conducted. The "SERIM Blood Leak Test Strips-2" themselves are a standalone diagnostic device. The reported sensitivity and specificity demonstrate the performance of the device independent of human interpretation ambiguity, beyond simply visual classification after the test is run. The device is the "algorithm" in this context (chemical reaction leading to a visual output).

    7. Type of Ground Truth Used

    • The ground truth for positive samples was established using a quantitative laboratory method: "1.5 mg/dL hemoglobin, determined by the cyanmethemoglobin method."
    • The ground truth for negative samples was "dialysis buffer without blood."

    8. Sample Size for the Training Set

    • The document does not describe a training set or a machine learning algorithm. This device is a chemical test strip, not an AI-based system. Therefore, the concept of a "training set" is not applicable in this context.

    9. How the Ground Truth for the Training Set Was Established

    • As the device is a chemical test strip and not an AI-based system, there is no "training set," and therefore, no process for establishing its ground truth.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1